Ambry Genetics

Ambry Genetics As a company built by scientists, genetic counselors and physicians, Ambry, a Tempus company, is your partner in genetics and genomics.

As a company built by scientists, genetic counselors and physicians, we are your partner in genetics and genomics.

Join us for a webinar on Wednesday, June 3, at 10 am PDT. Marissa Russell, MS, LGC, and Gregory Nogle will explore how o...
06/02/2026

Join us for a webinar on Wednesday, June 3, at 10 am PDT. Marissa Russell, MS, LGC, and Gregory Nogle will explore how ordering practices impact insurance coverage. Understand the ripple effect of ordering decisions on coverage, cost, and timely care, and get real-world guidance on minimizing administrative hurdles during the genetic testing process.
https://hubs.ly/Q04jPcmZ0

In a special Gene Scene Spotlight, Amanda Jacquart, MS, LCGC, covers MLH3. This gene is not on the ACMG Secondary Findin...
06/02/2026

In a special Gene Scene Spotlight, Amanda Jacquart, MS, LCGC, covers MLH3. This gene is not on the ACMG Secondary Findings List, however Ambry is dedicated to the search for new, evidence-backed insights that can meaningfully impact patient care. Our latest findings include additional evidence for MLH3, which has resulted in an upgraded gene-disease validity (GDV) for autosomal recessive polyposis and colorectal cancer predisposition.
https://hubs.ly/Q04jJbPT0

Genetic testing isn’t a one-time assessment—our understanding of DNA evolves as science advances. Ambry’s Patient for Li...
05/28/2026

Genetic testing isn’t a one-time assessment—our understanding of DNA evolves as science advances. Ambry’s Patient for Life™ program keeps your patients’ results up to date by automatically reanalyzing eligible tests and notifying you of important changes. No retesting needed.
Learn more at https://hubs.ly/Q04hVGB10

Moriah Melhado, MSPH, LCGC, explores Wilson disease associated with variants in the ATP7B gene. https://hubs.ly/Q...
05/26/2026

Moriah Melhado, MSPH, LCGC, explores Wilson disease associated with variants in the ATP7B gene.
https://hubs.ly/Q04hTH_n0

ICYMI: Ambry was first to offer clinical concurrent RNA and DNA testing in 2019 and in 2024 we added the power of RNA to...
05/22/2026

ICYMI: Ambry was first to offer clinical concurrent RNA and DNA testing in 2019 and in 2024 we added the power of RNA to exome testing. Ambry knows there are diagnostic and clinical benefits of RNA evidence. This study acts as a proof of concept that RNA sequencing can be integrated with rare‑disease workflows and demonstrates its feasibility and informativeness when paired with exome sequencing. Dive deeper into the power of RNA: https://hubs.ly/Q04htk8F0

Why are rare diseases so hard to diagnose and how is genetic testing changing that?Hear from Brad Power, Genomic Science...
05/20/2026

Why are rare diseases so hard to diagnose and how is genetic testing changing that?

Hear from Brad Power, Genomic Science Liaison Director, Rare Disease at Ambry Genetics, as we break it down and explore testing capabilities for patients still searching for answers on Doctor Radio Show on SiriusXM, Channel 110, May 20 at 6 PM ET/3 PM PT.

Listen on the SiriusXM app or online at https://hubs.ly/Q04hgTBP0

Our latest hereditary cancer menu enhancements are now available! Ambry is dedicated to the search for new, evidence-bac...
05/19/2026

Our latest hereditary cancer menu enhancements are now available!

Ambry is dedicated to the search for new, evidence-backed insights that can meaningfully impact patient care. Our latest findings include additional evidence for MLH3, which has resulted in an upgraded gene-disease validity (GDV) for autosomal recessive polyposis and colorectal cancer predisposition.

This upgraded GDV–along with existing medical management guidelines–is why we’ve enhanced CancerNext®, CancerNext–Expanded®, and ColoNext® to include MLH3 in the base panels.
https://hubs.ly/Q04h4WFk0

Haley Streff, MS, CGC, explores ventricular arrhythmias, including catecholaminergic polymorphic ventricular tachycardia...
05/19/2026

Haley Streff, MS, CGC, explores ventricular arrhythmias, including catecholaminergic polymorphic ventricular tachycardia (CPVT) and calcium release deficiency syndrome (CRDS), associated with variants in the RYR2 gene. https://hubs.ly/Q04h4WJ30

A recent study, published in Genetics in Medicine Open, showcases how targeted RNA analysis using Ambry’s ExomeReveal® w...
05/18/2026

A recent study, published in Genetics in Medicine Open, showcases how targeted RNA analysis using Ambry’s ExomeReveal® workflow can resolve uncertain findings and improve diagnostic clarity.
Dive deeper: https://hubs.ly/Q04gZ88R0

Join us for a webinar on Thursday, May 21, at 11 am PDT with Allison Wong, MS, CGC, and Setareh Zandihaghighi, MS, CGC. ...
05/14/2026

Join us for a webinar on Thursday, May 21, at 11 am PDT with Allison Wong, MS, CGC, and Setareh Zandihaghighi, MS, CGC. They will explore the efficacy of implementing multiple non-traditional service delivery models in community hospital-based cancer genetic clinics and the importance of equitable identification of those at increased risk for cancer.
Register today: https://hubs.ly/Q04gzg0V0

Address

15 Argonaut
Aliso Viejo, CA
92656

Website

Alerts

Be the first to know and let us send you an email when Ambry Genetics posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share